Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edit functionality is currently unavailable.

Ross I. Berbeco, Ph.D.


This page shows the publications co-authored by Ross Berbeco and Gerassimos Makrigiorgos.
Connection Strength

  1. Berbeco RI, Korideck H, Ngwa W, Kumar R, Patel J, Sridhar S, Johnson S, Price BD, Kimmelman A, Makrigiorgos GM. DNA damage enhancement from gold nanoparticles for clinical MV photon beams. Radiat Res. 2012 Dec; 178(6):604-8.
    View in: PubMed
    Score: 0.577
  2. Berbeco RI, Ngwa W, Makrigiorgos GM. Localized dose enhancement to tumor blood vessel endothelial cells via megavoltage X-rays and targeted gold nanoparticles: new potential for external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2011 Sep 01; 81(1):270-6.
    View in: PubMed
    Score: 0.505
  3. Detappe A, Kunjachan S, Sancey L, Motto-Ros V, Biancur D, Drane P, Guieze R, Makrigiorgos GM, Tillement O, Langer R, Berbeco R. Corrigendum to "Advanced multimodal nanoparticles delay tumor progression withclinical radiation therapy" [Journal of Controlled Release 238 (2016) 103-133]. J Control Release. 2020 Sep 22.
    View in: PubMed
    Score: 0.249
  4. Virani NA, Kelada OJ, Kunjachan S, Detappe A, Kwon J, Hayashi J, Vazquez-Pagan A, Biancur DE, Ireland T, Kumar R, Sridhar S, Makrigiorgos GM, Berbeco RI. Noninvasive imaging of tumor hypoxia after nanoparticle-mediated tumor vascular disruption. PLoS One. 2020; 15(7):e0236245.
    View in: PubMed
    Score: 0.246
  5. Detappe A, Kunjachan S, Sancey L, Motto-Ros V, Biancur D, Drane P, Guieze R, Makrigiorgos GM, Tillement O, Langer R, Berbeco R. Advanced multimodal nanoparticles delay tumor progression with clinical radiation therapy. J Control Release. 2016 09 28; 238:103-113.
    View in: PubMed
    Score: 0.186
  6. Kunjachan S, Detappe A, Kumar R, Ireland T, Cameron L, Biancur DE, Motto-Ros V, Sancey L, Sridhar S, Makrigiorgos GM, Berbeco RI. Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy. . 2015 Nov 11; 15(11):7488-96.
    View in: PubMed
    Score: 0.176
  7. Ngwa W, Kumar R, Sridhar S, Korideck H, Zygmanski P, Cormack RA, Berbeco R, Makrigiorgos GM. Targeted radiotherapy with gold nanoparticles: current status and future perspectives. Nanomedicine (Lond). 2014 May; 9(7):1063-82.
    View in: PubMed
    Score: 0.160
  8. Ngwa W, Makrigiorgos GM, Berbeco RI. Gold nanoparticle enhancement of stereotactic radiosurgery for neovascular age-related macular degeneration. Phys Med Biol. 2012 Oct 21; 57(20):6371-80.
    View in: PubMed
    Score: 0.143
  9. Ngwa W, Tsiamas P, Zygmanski P, Makrigiorgos GM, Berbeco RI. A multipurpose quality assurance phantom for the small animal radiation research platform (SARRP). Phys Med Biol. 2012 May 07; 57(9):2575-86.
    View in: PubMed
    Score: 0.138
  10. Ngwa W, Makrigiorgos GM, Berbeco RI. Gold nanoparticle-aided brachytherapy with vascular dose painting: estimation of dose enhancement to the tumor endothelial cell nucleus. Med Phys. 2012 Jan; 39(1):392-8.
    View in: PubMed
    Score: 0.136
  11. Ngwa W, Korideck H, Chin LM, Makrigiorgos GM, Berbeco RI. MOSFET assessment of radiation dose delivered to mice using the Small Animal Radiation Research Platform (SARRP). Radiat Res. 2011 Dec; 176(6):816-20.
    View in: PubMed
    Score: 0.133
  12. Ngwa W, Makrigiorgos GM, Berbeco RI. Applying gold nanoparticles as tumor-vascular disrupting agents during brachytherapy: estimation of endothelial dose enhancement. Phys Med Biol. 2010 Nov 07; 55(21):6533-48.
    View in: PubMed
    Score: 0.125
  13. Li J, Wang L, Mamon H, Kulke MH, Berbeco R, Makrigiorgos GM. Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing. Nat Med. 2008 May; 14(5):579-84.
    View in: PubMed
    Score: 0.105
  14. Li J, Berbeco R, Distel RJ, Jänne PA, Wang L, Makrigiorgos GM. s-RT-MELT for rapid mutation scanning using enzymatic selection and real time DNA-melting: new potential for multiplex genetic analysis. Nucleic Acids Res. 2007; 35(12):e84.
    View in: PubMed
    Score: 0.099
  15. Herter-Sprie GS, Korideck H, Christensen CL, Herter JM, Rhee K, Berbeco RI, Bennett DG, Akbay EA, Kozono D, Mak RH, Makrigiorgos GM, Kimmelman AC, Wong KK. Author Correction: Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models. Nat Commun. 2020 Apr 09; 11(1):1835.
    View in: PubMed
    Score: 0.060
  16. Kumar R, Korideck H, Ngwa W, Berbeco RI, Makrigiorgos GM, Sridhar S. Third generation gold nanoplatform optimized for radiation therapy. Transl Cancer Res. 2013 Aug; 2(4).
    View in: PubMed
    Score: 0.038
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.